RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

SCALP Trade vs Crypto Fund Trader

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

SCLT

SCALP Trade

EST. 2009

CRFT

Crypto Fund Trader

EST. 2022

SCALP TRADE

METRIC

CRYPTO FUND TRADER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

$200,000

—

MIN COST

$5,000

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

SCALP TRADE DETAILS

STEPS: -phase
MARKETS: Stocks

CRYPTO FUND TRADER DETAILS

STEPS: -phase
MARKETS: Crypto
PLATFORMS: MT5

SCALP Trade PROS

+Offers Stocks trading, a relatively uncommon market among prop firms providing niche opportunity
+Founded in 2009, giving it over 15 years of operational history and longevity
+Placeholder pro — limited data prevents further above-average metric identification
+Placeholder pro — limited data prevents further above-average metric identification

SCALP Trade CONS

−No profit split, funding cap, drawdown, or payout data is available for comparison
−Absence of key metrics makes it impossible to evaluate this firm against industry averages
−Limited data is itself a transparency concern for traders making financial decisions

Crypto Fund Trader PROS

+Crypto-focused offering provides niche market access unavailable at most prop firms
+Based in Switzerland, a well-regulated and reputable financial hub
+Founded in 2022, indicating an established operational track record
+Offers MT5, a widely used and trusted trading platform

Crypto Fund Trader CONS

−Min challenge cost of $5,000 is vastly higher than the industry average of $186.7
−Max funding of $200,000 is well below the industry average of $839,272.70
−No profit split, drawdown, or profit target data provided, limiting informed comparison

PROPDNA VERDICT